|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| C07B 59/00 | |||
| A61K 31/519 |
| (11) | Number of the document | 2882751 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13745554.9 |
| Date of filing the European patent application | 2013-07-30 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/052721 |
| Date | 2013-07-30 |
| (87) | Number | WO 2014/022390 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| 201261677307 P | 2012-07-30 | US |
| (72) |
TUNG, Roger, D., US
MORGAN, Adam, J., US
|
| (73) |
Concert Pharmaceuticals Inc.,
99 Hayden Avenue, Suite 500, Lexington, MA 02421,
US
|
| (54) | DEUTERATED IBRUTINIB |
| DEUTERATED IBRUTINIB |